Co-op 使用法醫噴霧標記常被盜物品,以追蹤轉售行為
• 隨著新零售犯罪法律生效,一系列措施已幫助去年店內犯罪率降低了五分之一。 • Co-op 正秘密地在包括酒精飲料和洗衣劑在內的高風險盜竊商品上標記不可見的「法醫噴霧」以進行追蹤,這是針對商店盜竊的最新打擊行動。 • 該超市在曼徹斯特和倫敦自去年起進行測試後,將在全國範圍內採用這項技術,以幫助零售商識別盜竊物品的轉售地點並向警方舉報。
theguardian.com由 AI 驅動,附引用來源
Comprehensive coverage and timeline for Spray. Aggregated from 4 sources with 5 articles.
5 篇文章 · 4 個來源 · 自 4/1/2026 起的報導
Spray 報導隨時間的發展情況。
經常與 Spray 一起報導的話題。
• 隨著新零售犯罪法律生效,一系列措施已幫助去年店內犯罪率降低了五分之一。 • Co-op 正秘密地在包括酒精飲料和洗衣劑在內的高風險盜竊商品上標記不可見的「法醫噴霧」以進行追蹤,這是針對商店盜竊的最新打擊行動。 • 該超市在曼徹斯特和倫敦自去年起進行測試後,將在全國範圍內採用這項技術,以幫助零售商識別盜竊物品的轉售地點並向警方舉報。
theguardian.com
圖片:Texas A&M University• Texas A&M researchers developed a nasal spray therapy that reverses brain aging by healing inflammation and restoring memory function. • The treatment targets age-related cognitive decline, turning 'brain fog to brain focus' in preclinical models. • Announced on April 14, 2026, it reshapes future therapies for neurodegenerative diseases.
stories.tamu.edu• FDA approved Haleon's Narcan 4mg nasal spray for non-prescription sale on April 7, 2026, building on 2023 authorization. • Reversal success rate 98% in trials with 150 US overdose simulations; priced at $29.95 for two-pack. • Addresses 110,000 annual US opioid deaths; 'Lifeline for bystanders,' says FDA Commissioner.
bloomberg.comNSW follows Queensland, South Australia and Western Australia in offering free treatments for kids four and under, saving up to $70Get our breaking news email, free app or daily news podcastHundreds of thousands of children will be able to access a painless, needle-free flu vaccination for free as governments attempt to curb falling vaccine rates.New South Wales has become the latest state to offer a nasal spray flu vaccine to children for free, following Queensland, South Australia and Western Australia. Continue reading...
theguardian.com• Express Scripts added CARDAMYST (etripamil) nasal spray to its commercial national formularies effective March 27, 2026, expanding access for commercially insured patients. • The FDA-approved self-administered spray converts acute paroxysmal supraventricular tachycardia (PSVT) episodes to sinus rhythm in adults. • This coverage decision makes the first-in-class treatment broadly affordable across the U.S., improving cardiovascular care options.
investors.milestonepharma.com